Home

About Us
   Programs
   Results
   Mission/Vision
   Leadership

Support Us

Research Awards
   About
   Impact
   Award Recipients

Collaboration
   Clinical Network
   Preclinical Screening
   Industry

News Room

Resources/Information
   Learn from the Experts
   Statistics
   Clinical Trials
   Additional Resources

Contact Us
Clinical Network

To accelerate the transition of therapies into clinical studies for patients, Accelerate Brain Cancer Cure has initiated a strategic collaboration, the ABC2 Clinical Network. It is composed of four leading neuro-oncology centers and clinical investigators who work together to:
  • Provide guidance and counsel to the sponsors of drug therapies, particularly in the early stages of designing clinical trials;
  • Assist ABC2 in evaluating the potential or readiness of promising drug therapies for clinical trials; and
  • Conduct clinical trials of these therapies.
The ABC2 Clinical Network serves as a resource to patients and the scientific and medical communities. Members include the Preston Robert Tisch Brain Tumor Center at Duke University, the M.D. Anderson Cancer Center, the University of California-Los Angeles, and the University of California-San Francisco. It is the vehicle through which ABC2 translates successes in the lab into meaningful treatment options for brain cancer patients and their families.
Content copyright © 2009 Accelerate Brain Cancer Cure, Inc.